Financhill
Back

Relmada Therapeutics Stock Predictions

Relmada Therapeutics Stock Forecast

  • Is Relmada Therapeutics Stock Undervalued?
    The current Relmada Therapeutics [RLMD] share price is $0.36. The Score for RLMD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Relmada Therapeutics Stock Go Up Next Year?

Data Unavailable

Relmada Therapeutics Stock Rating

Data Unavailable

Relmada Therapeutics Stock Price History

Is RLMD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
relmada.com

52-Week Data

52-Week High:
7.22
52-Week Low:
0.34

Prediction Charts

Market Cap:
11M
Price in USD:
0.36
Volume:
424K
Beta:
0.16

Technical Analysis

SMA50:
2.53
SMA100:
2.78
SMA200:
3.35
52-Wk Change:
-85.18%

Stock Predictions

  • Is Relmada Therapeutics stock public?
    Yes, Relmada Therapeutics is a publicly traded company.
  • What is the Relmada Therapeutics stock quote today?
    The Relmada Therapeutics stock price is 0.36 USD today.
  • How to buy Relmada Therapeutics stock online?
    You can buy Relmada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 3.25 2.77 3.25 2.76
Dec-4 0.70 0.63 0.73 0.62
Dec-5 0.64 0.45 0.64 0.44
Dec-6 0.46 0.46 0.49 0.43
Dec-9 0.50 0.48 0.51 0.46
Dec-10 0.50 0.47 0.50 0.46
Dec-11 0.46 0.42 0.46 0.42
Dec-12 0.40 0.37 0.42 0.36
Dec-13 0.36 0.37 0.37 0.35
Dec-16 0.35 0.39 0.41 0.35
Dec-17 0.38 0.36 0.39 0.35
Dec-18 0.35 0.35 0.40 0.35
Dec-19 0.35 0.35 0.37 0.34
Dec-20 0.34 0.36 0.38 0.34

Relmada Therapeutics Earnings

Data Unavailable

Relmada Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.41 per share.

* Relmada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.